World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
42
Citations
8279
World Ranking
4882
National Ranking
2185

Janice G. McFarland publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Janice G. McFarland sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 89 publications — 1st percentile

1% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Janice G. McFarland D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Janice G. McFarland sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 42 D-Index — 1st percentile

1% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Janice G. McFarland is affiliated with the Medical College of Wisconsin in the United States. Their research spans multiple fields, primarily within medicine, but also extending into business, management, and accounting.

Their scholarly work involves several interdisciplinary subfields including critical care and intensive care medicine, biochemistry, and management of technology and innovation. These areas reflect a diverse approach to both clinical and administrative aspects of healthcare and scientific research.

Key topics addressed in their research include trauma, hemostasis, coagulopathy, and resuscitation. Additionally, they focus on blood transfusion and management as well as blood donation and transfusion practices. These themes highlight a concentration on improving outcomes related to bleeding disorders and transfusion protocols.

McFarland's recent publication record includes the paper titled Dose of Prophylactic Platelet Transfusions and Prevention of Hemorrhage, published in 2020 within the UNC Libraries venue. This work contributes to the understanding of prophylactic platelet transfusions in clinical settings.

Throughout their career, Janice G. McFarland has collaborated with several researchers, including:

  • Sherrill J. Slichter
  • Richard M. Kaufman
  • Susan F. Assmann
  • Jeffrey McCullough
  • Darrell J. Triulzi

Their publications have appeared primarily in UNC Libraries, indicating a consistent relationship with this platform for disseminating research outputs.

Best Publications

  • Dose of prophylactic platelet transfusions and prevention of hemorrhage.

    Sherrill J. Slichter;Richard M. Kaufman;Susan F. Assmann;Jeffrey McCullough

  • Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients

    Sherrill J. Slichter;Kathryn Davis;Helen Enright;Hayden Braine

  • Antenatal treatment of neonatal alloimmune thrombocytopenia.

    James B. Bussel;Richard L. Berkowitz;Janice G. McFarland;Lauren Lynch

  • Fetal Alloimmune Thrombocytopenia

    James B. Bussel;Marcia R. Zabusky;Richard L. Berkowitz;Janice G. McFarland

  • Fetal alloimmune thrombocytopenia

    James B. Bussel;Marcia R. Zabusky;Richard L. Berkowitz;Janice G. McFarland

  • Vancomycin-induced immune thrombocytopenia.

    Annette Von Drygalski;Brian R. Curtis;Daniel W. Bougie;Janice G. McFarland

  • Antenatal management of alloimmune thrombocytopenia with intravenous γ-globulin: A randomized trial of the addition of low-dose steroid to intravenous γ-globulin

    James B. Bussel;Richard L. Berkowitz;Lauren Lynch;Martin L. Lesser

  • Efficacy of transfusion with granulocytes from G-CSF/dexamethasone–treated donors in neutropenic patients with infection

    Thomas H. Price;Michael Boeckh;Michael Boeckh;Ryan W. Harrison;Jeffrey McCullough

  • TRALI due to granulocyte-agglutinating human neutrophil antigen-3a (5b) alloantibodies in donor plasma: a report of 2 fatalities

    A. Davoren;B.R. Curtis;I.A. Shulman;A.F. Mohrbacher

  • Parallel randomized trials of risk-based therapy for fetal alloimmune thrombocytopenia.

    Richard L. Berkowitz;E Anders Kolb;Janice G. McFarland;Megan Wissert

  • Neonatal alloimmune thrombocytopenia: pathogenesis, diagnosis and management

    Julie A. Peterson;Janice G. McFarland;Brian R. Curtis;Richard H. Aster

  • Alloimmune thrombocytopenia: Fetal and neonatal losses related to cordocentesis

    Michael J. Paidas;Michael J. Paidas;Richard L. Berkowitz;Richard L. Berkowitz;Lauren Lynch;Lauren Lynch;Charles J. Lockwood;Charles J. Lockwood

  • Heparin is not required for detection of antibodies associated with heparin-induced thrombocytopenia/thrombosis

    Gian Paolo Visentin;Michael Moghaddam;Sheila E. Beery;Janice G. McFarland

  • Rapid determination of platelet alloantigen genotypes by polymerase chain reaction using allele-specific primers

    Skogen B;Bellissimo Db;Hessner Mj;Santoso S

  • Clinical and diagnostic comparison of neonatal alloimmune thrombocytopenia to non-immune cases of thrombocytopenia.

    James B Bussel;Stergios Zacharoulis;Kim Kramer;Janice G McFarland

  • Thrombocytopenia after second exposure to abciximab is caused by antibodies that recognize abciximab-coated platelets

    Brian R. Curtis;Julia Swyers;Ajit Divgi;Janice G. McFarland

  • Antenatal treatment of alloimmune thrombocytopenia.

    L Lynch;J B Bussel;J G McFarland;U Chitkara

  • Immune-mediated thrombocytopenia resulting from sensitivity to oxaliplatin

    Brian R. Curtis;James Kaliszewski;Marisa B. Marques;M. Wasif Saif

  • Mechanisms of transfusion-related acute lung injury (TRALI): Anti-leukocyte antibodies

    Brian R. Curtis;Janice G. McFarland

  • Quinine-induced immune thrombocytopenia with hemolytic uremic syndrome : clinical and serological findings in nine patients and review of literature

    Jerome L. Gottschall;Betsy Neahring;Janice G. McFarland;Guo‐Guang Wu

  • Quinine-induced immune thrombocytopenia associated with hemolytic uremic syndrome: a new clinical entity

    Jerome L. Gottschall;William Elliot;Elias Lianos;Janice G. McFarland

  • Fetal and neonatal alloimmune thrombocytopenia: a management algorithm based on risk stratification.

    Luis D. Pacheco;Richard L. Berkowitz;Kenneth J. Moise;James B. Bussel

  • Recommendations for the evaluation and treatment of neonatal autoimmune and alloimmune thrombocytopenia. The Working Party on Neonatal Immune Thrombocytopenia of the Neonatal Hemostasis Subcommittee of the Scientific and Standardization Committee of the ISTH.

    J Bussel;C Kaplan;J McFarland

  • An amino acid polymorphism within the RGD binding domain of platelet membrane glycoprotein IIIa is responsible for the formation of the Pena/Penb alloantigen system.

    Ronggang Wang;K. Furihata;J. G. Mcfarland;K. Friedman

  • Clinicopathologic features of agranulocytosis in the setting of levamisole-tainted cocaine.

    David R. Czuchlewski;Monica Brackney;Christina Ewers;Jonaki Manna

Frequent Co-Authors

Richard H. Aster
Richard H. Aster Medical College of Wisconsin
Brian R. Curtis
Brian R. Curtis University of Wisconsin–Milwaukee
James B. Bussel
James B. Bussel Cornell University
Richard L. Berkowitz
Richard L. Berkowitz Columbia University
Demin Wang
Demin Wang Medical College of Wisconsin
Jeffrey McCullough
Jeffrey McCullough University of Minnesota
Martin Lesser
Martin Lesser Feinstein Institute for Medical Research
Paul M. Ness
Paul M. Ness Johns Hopkins University
Thomas S. Kickler
Thomas S. Kickler Johns Hopkins University School of Medicine
Thomas L. Ortel
Thomas L. Ortel Duke University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open diverse career opportunities. Many students who begin in immunology later consider advancing their practical skills through nursing programs. For instance, non-nurses looking to enter the field might find value in online nursing programs for non nurses, which offer flexible paths into nursing without prior healthcare experience.

Accelerated nursing options are also popular, especially for individuals who want to transition quickly. Identifying the easiest absn program to get into can help prospective students find a fast yet manageable route into becoming a Registered Nurse (RN).

For those aiming for foundational nursing roles, understanding easy admission lpn programs is crucial. These Licensed Practical Nurse (LPN) programs act as a stepping stone in healthcare, providing essential clinical experience.

Lastly, nurse practitioners represent an advanced career track. Exploring what is the easiest np program offers insight into accessible routes for higher-level clinical authority and specialization, complementary to an immunology background.

Best Scientists Citing Janice G. McFarland

Trending Scientists

Recently Published Articles